2,3-DI-TERT.-BUTYLTHIAZIRIDIN-1,1-DIOXID = DIOXYDE-1,1 DE DI-T-BUTYL-2,3 THIAZIRIDINEQUAST H; KEES F.1974; ANGEW. CHEM.; DTSCH.; DA. 1974; VOL. 86; NO 22; PP. 816-817; BIBL. 15 REF.Article

TRANS-2,3-DI-TERT-BUTYLTHIIRAN-1,1-DIOXID UND 2,5-DI-TERT-BUTYL-2,5-DIHYDRO-1,3,4-THIADIAZOL-1,1-DIOXIDE AUS TERT-BUTYLDIAZOMETHAN UND SCHWEFELDIOXID. SOLVENSEFFEKTE UND MECHANISMEN DER STAUDINGER-PFENNINGER-REAKTION = TRANS-DI-T-BUTYL-2,3 THIIRANNE DIOXYDE-1,1 ET DI-T-BUTYL DIHYDRO-2,5 THIADIAZOLE-1,3,4 DIOXYDE-1,1 A PARTIR DE T-BUTYLDIAZOMETHANE ET DE SO₂. EFFET DE SOLVANT ET MECANISME DE LA REACTION DE STANDINGER-PFENNIGERQUAST H; KEES F.1981; CHEM. BER.; ISSN 0009-2940; DEU; DA. 1981; VOL. 114; NO 2; PP. 787-801; ABS. ENG; BIBL. 53 REF.Article

SYNTHESE UND ZERFALL EINES THIADIAZIRIDIN-1,1-DIOXIDS. = SYNTHESE ET DECOMPOSITION D'UN DIOXYDE-1,1 DE THIADIAZIRIDINEQUAST H; KEES F.1977; CHEM. BER.; DTSCH.; DA. 1977; VOL. 110; NO 5; PP. 1780-1791; ABS. ANGL.; BIBL. 56 REF.Article

THERMISCHER ZERFALL ISOMERER DIHYDRO-1,3,4-THIADIAZOL-1,1-DIOXIDE = DECOMPOSITION THERMIQUE DES ISOMERES DU DIOXYDE-1,1 DE DIHYDRO-THIADIAZOLE-1,3,4QUAST H; KEES F.1981; CHEM. BER.; ISSN 0009-2940; DEU; DA. 1981; VOL. 114; NO 2; PP. 802-807; ABS. ENG; BIBL. 26 REF.Article

COMPARATIVE DETERMINATION OF CEFOTAXIME AND DESACETYL CEFOTAXIME IN SERUM AND BILE BY BIOASSAY AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYKEES F; STREHL E; SEEGER K et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 2; PP. 362-365; ABS. GER; BIBL. 10 REF.Article

3-HYDROXY-PHOSPHABENZOL-EIN "PHOSPHAPHENOL". = HYDROXY-3 PHOSPHABENZENE, UN "PHOSPHAPHENOL".MARKL G; ADOLIN G; KEES F et al.1977; TETRAHEDRON LETTERS; G.B.; DA. 1977; NO 39; PP. 3445-3448; BIBL. 7 REF.Article

Structuring of edible oils by alternatives to crystalline fatPEMETTI, Minima; VAN MALSSEN, Kees F; FLÖTER, Eckhard et al.Current opinion in colloid & interface science. 2007, Vol 12, Num 4-5, pp 221-231, issn 1359-0294, 11 p.Article

Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by high-performance liquid chromatographyKEES, F; JEHNICH, D; GROBECKER, H et al.Journal of chromatography. B, Biomedical applications. 1996, Vol 677, Num 1, pp 172-177Article

Sympathoadrenal dysfunction in rats with chronic neurogenic hypertensionDOMINIAK, P; KEES, F; GROBECKER, H et al.European journal of pharmacology. 1985, Vol 107, Num 2, pp 263-266, issn 0014-2999Article

Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteersKEES, F; WELLENHOFER, M; GROBECKER, H et al.Infection. 1995, Vol 23, Num 3, pp 168-172, issn 0300-8126Article

Untersuchungen zur Bioverfügbarkeit von Heptaminol bei Probanden = Etudes de biodisponibilité de l'heptaminol chez des volontaires = Bioavailability studies of heptaminol in healthy volunteersKEES, F; DOMINIAK, P; GROBECKER, H et al.Arzneimittel-Forschung. 1987, Vol 37, Num 10, pp 1182-1185, issn 0004-4172Article

Inhibition of monoamine oxidase by viloxazine in ratsMARTINEZ, C; DOMINIAK, P; KEES, F et al.Arzneimittel-Forschung. 1986, Vol 36, Num 5, pp 800-803, issn 0004-4172Article

Determination of opipramol in human plasma by high-performance liquid chromatography with photometric detection using a cyanopropyl columnKEES, F; BUCHER, M; MAIR, G et al.Journal of chromatography. B, Biomedical sciences and applications. 2001, Vol 753, Num 2, pp 337-342, issn 1387-2273Article

Pharmacological properties of parenteral cephalosporins : Rationale for ambulatory useSTREHL, E; KEES, F.Drugs (Basel). 2000, Vol 59, pp 9-18, issn 0012-6667, SUP3Article

Inhibition of monoamine oxidase by viloxazine in ratsMARTINEZ, C; DOMINIAK, P; KEES, F et al.Arzneimittel-Forschung. 1986, Vol 36, Num 5, pp 800-803, issn 0004-4172Article

Effect of roxithromycin on the pharmacokinetics of lovastatin in volunteersBUCHER, M; MAIR, G; KEES, F et al.European journal of clinical pharmacology. 2002, Vol 57, Num 11, pp 787-791, issn 0031-6970Article

Bioavailability of cefpodoxime proxetil with co-administered acetylcysteineKEES, F; WELLENHOFER, M; BRÖHL, K et al.Arzneimittel-Forschung. 1996, Vol 46, Num 4, pp 435-438, issn 0004-4172Article

Strukturelle Charakterisierung eines unbekannten Metaboliten von Ciprofloxacin = Structural characterization of an unknown metabolite of ciprofloxacinKEES, F; RAASCH, W; GROBECKER, H et al.Arzneimittel-Forschung. 1992, Vol 42, Num 4, pp 570-575, issn 0004-4172Article

High-performance liquid chromatographic assay for cefotiam and d3-cefotiam in human serumKEES, F; RAASCH, W; STEGER, M et al.Journal of chromatography. Biomedical applications. 1990, Vol 525, Num 2, pp 484-489, issn 0378-4347Article

Circulating and tissue catecholamines in rats with chronic neurogenic hypertensionDOMINIAK, P; KEES, F; GROBECKER, H et al.Basic research in cardiology. 1986, Vol 81, Num 1, pp 20-28, issn 0300-8428Article

High-performance liquid chromatographic analysis of cefotetan epimers in human plasma and urineKEES, F; GROBECKER, H; NABER, K. G et al.Journal of chromatography. 1984, Vol 305, Num 2, pp 363-371, issn 0021-9673Article

Comparative investigations on the bioavailability of cefuroxime axetilKEES, F; LUKASSEK, U; NABER, K. G et al.Arzneimittel-Forschung. 1991, Vol 41, Num 8, pp 843-846, issn 0004-4172Article

Pharmacokinetics of ciprofloxacin in elderly patientsKEES, F; NABER, K. G; MEYER, G. P et al.Arzneimittel-Forschung. 1989, Vol 39, Num 4, pp 523-527, issn 0004-4172Article

Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissueKEES, F; NABER, K. G; SCHUMACHER, H et al.Chemotherapy (Basel). 1988, Vol 34, Num 6, pp 437-443, issn 0009-3157Article

Untersuchungen zur Bioverfügbarkeit von Midodrin und α-2,5-Dimethoxyphenyl-β-aminoethanol-hydrochlorid = Etudes sur la biodisponibilité du Midodrine et de l'α-2,5-dimethoxyphenyl-β-aminoethanol chlorhydrate = Studies on the bioavailability of Midodrine and α-2,5,-dimethoxyphenyl-β-aminoethanol hydrochlorideGROBECKER, H; KEES, F; LINDEN, M et al.Arzneimittel-Forschung. 1987, Vol 37, Num 4, pp 447-450, issn 0004-4172Article